QQQ   298.44 (-1.16%)
AAPL   145.54 (-1.07%)
MSFT   261.50 (+0.15%)
FB   200.04 (+0.71%)
GOOGL   2,288.90 (-1.38%)
AMZN   2,216.21 (-1.99%)
TSLA   724.37 (-5.88%)
NVDA   172.64 (-2.50%)
BABA   86.48 (-1.72%)
NIO   14.55 (+1.68%)
AMD   94.24 (-0.93%)
CGC   5.73 (-3.21%)
MU   70.47 (-2.02%)
T   20.28 (+2.22%)
GE   74.63 (-0.56%)
F   13.05 (-3.33%)
DIS   105.18 (-2.00%)
AMC   11.71 (-0.85%)
PFE   50.67 (+1.50%)
PYPL   77.65 (-1.50%)
NFLX   186.51 (-0.60%)
QQQ   298.44 (-1.16%)
AAPL   145.54 (-1.07%)
MSFT   261.50 (+0.15%)
FB   200.04 (+0.71%)
GOOGL   2,288.90 (-1.38%)
AMZN   2,216.21 (-1.99%)
TSLA   724.37 (-5.88%)
NVDA   172.64 (-2.50%)
BABA   86.48 (-1.72%)
NIO   14.55 (+1.68%)
AMD   94.24 (-0.93%)
CGC   5.73 (-3.21%)
MU   70.47 (-2.02%)
T   20.28 (+2.22%)
GE   74.63 (-0.56%)
F   13.05 (-3.33%)
DIS   105.18 (-2.00%)
AMC   11.71 (-0.85%)
PFE   50.67 (+1.50%)
PYPL   77.65 (-1.50%)
NFLX   186.51 (-0.60%)
QQQ   298.44 (-1.16%)
AAPL   145.54 (-1.07%)
MSFT   261.50 (+0.15%)
FB   200.04 (+0.71%)
GOOGL   2,288.90 (-1.38%)
AMZN   2,216.21 (-1.99%)
TSLA   724.37 (-5.88%)
NVDA   172.64 (-2.50%)
BABA   86.48 (-1.72%)
NIO   14.55 (+1.68%)
AMD   94.24 (-0.93%)
CGC   5.73 (-3.21%)
MU   70.47 (-2.02%)
T   20.28 (+2.22%)
GE   74.63 (-0.56%)
F   13.05 (-3.33%)
DIS   105.18 (-2.00%)
AMC   11.71 (-0.85%)
PFE   50.67 (+1.50%)
PYPL   77.65 (-1.50%)
NFLX   186.51 (-0.60%)
QQQ   298.44 (-1.16%)
AAPL   145.54 (-1.07%)
MSFT   261.50 (+0.15%)
FB   200.04 (+0.71%)
GOOGL   2,288.90 (-1.38%)
AMZN   2,216.21 (-1.99%)
TSLA   724.37 (-5.88%)
NVDA   172.64 (-2.50%)
BABA   86.48 (-1.72%)
NIO   14.55 (+1.68%)
AMD   94.24 (-0.93%)
CGC   5.73 (-3.21%)
MU   70.47 (-2.02%)
T   20.28 (+2.22%)
GE   74.63 (-0.56%)
F   13.05 (-3.33%)
DIS   105.18 (-2.00%)
AMC   11.71 (-0.85%)
PFE   50.67 (+1.50%)
PYPL   77.65 (-1.50%)
NFLX   186.51 (-0.60%)
OTCMKTS:PBSV

Pharma-Bio Serv (PBSV) Stock Forecast, Price & News

$0.95
+0.12 (+14.45%)
(As of 05/16/2022 03:58 PM ET)
Add
Compare
Today's Range
$0.84
$0.95
50-Day Range
$0.83
$0.95
52-Week Range
$0.77
$1.34
Volume
650 shs
Average Volume
6,003 shs
Market Capitalization
$22.28 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.31
30 days | 90 days | 365 days | Advanced Chart
Receive PBSV News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter.

Pharma-Bio Serv logo

About Pharma-Bio Serv

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm. The company provides compliance consulting services to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products companies in Puerto Rico, the United States, Europe, and Brazil. Its technical consulting services comprise regulatory compliance, validation, technology transfer, engineering, project management, and process support. The company was founded in 1993 and is headquartered in Dorado, Puerto Rico.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Management consulting services
Sub-Industry
N/A
Current Symbol
OTCMKTS:PBSV
Employees
190
Year Founded
N/A

Sales & Book Value

Annual Sales
$20.11 million
Book Value
$0.81 per share

Profitability

Net Income
$-2.09 million
Pretax Margin
-8.92%

Debt

Price-To-Earnings

Miscellaneous

Free Float
20,643,000
Market Cap
$22.28 million
Optionable
Not Optionable

Company Calendar

Ex-Dividend for 3/15 Dividend
2/24/2022
Dividend Payable
3/15/2022
Last Earnings
3/17/2022
Today
5/16/2022
Fiscal Year End
10/31/2022

MarketRank

Overall MarketRank

1.39 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 1.9 5 -4 -3 -2 -1 -













Pharma-Bio Serv (OTCMKTS:PBSV) Frequently Asked Questions

How were Pharma-Bio Serv's earnings last quarter?

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) announced its earnings results on Thursday, March, 17th. The company reported $0.01 earnings per share (EPS) for the quarter. The business earned $5.02 million during the quarter. Pharma-Bio Serv had a negative net margin of 9.94% and a negative trailing twelve-month return on equity of 10.05%.
View Pharma-Bio Serv's earnings history
.

How often does Pharma-Bio Serv pay dividends? What is the dividend yield for Pharma-Bio Serv?

Pharma-Bio Serv announced a dividend on Friday, February 18th. Investors of record on Friday, February 25th will be paid a dividend of $0.075 per share on Tuesday, March 15th. This represents a dividend yield of 16.13%. The ex-dividend date is Thursday, February 24th.
View Pharma-Bio Serv's dividend history
.

Who are Pharma-Bio Serv's key executives?
Pharma-Bio Serv's management team includes the following people:
  • Mr. Victor Sanchez, CEO, Pres & Pres of European Operations (Age 51, Pay $346.55k)
  • Ms. Elizabeth Plaza, Founder & Sr. Strategic Consultant (Age 58, Pay $69.92k)
  • Mr. Pedro J. Lasanta, CFO, VP of Fin. & Admin. and Sec. (Age 62, Pay $250.6k)
  • Ms. Miriam Marrero M.B.A., HR Mang.
What other stocks do shareholders of Pharma-Bio Serv own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pharma-Bio Serv investors own include Zynerba Pharmaceuticals (ZYNE), Allena Pharmaceuticals (ALNA), AstroNova (ALOT), Oracle (ORCL), AT&T (T), Yintech Investment (YIN), Aeglea BioTherapeutics (AGLE), Ampliphi Biosciences (APHB), Carnival Co. & (CCL) and Earthstone Energy (ESTE).

What is Pharma-Bio Serv's stock symbol?

Pharma-Bio Serv trades on the OTCMKTS under the ticker symbol "PBSV."

How do I buy shares of Pharma-Bio Serv?

Shares of PBSV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pharma-Bio Serv's stock price today?

One share of PBSV stock can currently be purchased for approximately $0.95.

How much money does Pharma-Bio Serv make?

Pharma-Bio Serv has a market capitalization of $22.28 million and generates $20.11 million in revenue each year. The company earns $-2.09 million in net income (profit) each year or ($0.09) on an earnings per share basis.

How many employees does Pharma-Bio Serv have?

Pharma-Bio Serv employs 190 workers across the globe.

What is Pharma-Bio Serv's official website?

The official website for Pharma-Bio Serv is www.pharmabioserv.com.

How can I contact Pharma-Bio Serv?

Pharma-Bio Serv's mailing address is Pharma-Bio Serv Building Suite 6 Road 696, DORADO PR, 00646. The company can be reached via phone at (787) 278-2709, via email at [email protected], or via fax at 787-796-5168.

This page was last updated on 5/16/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.